The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors

American Journal of Clinical Pathology

Volumn 107, Issue 3, 1997, Pages 321-331

  Kiss, Robert ^a,b,c   Dewitte, Olivier ^a   Decaestecker, Christine ^a   Camby, Isabelle ^a,b   Gordower, Laurence ^a   Delbecque, Katty ^a   Pasteels, Jean Lambert ^a   Brotchi, Jacques ^a   Salmon, Isabelle ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b FNRS   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Astrocytic tumor; Cell density; Cell loss; Feulgen staining; Image cytometry; Patient survival; Proliferative activity; Quantitative measurements

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

EID: 0031040544     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.3.321     Document Type: Article

References (31)

1. Burger PC, Scheithauer BW, Vogel FS, eds. Surgical Pathology of the Nervous System and Its Coverings. 3rd ed. New York, NY: Churchill Livingstone; 1991.
2. Kleihues P, Burger PC, Scheithauer BW, eds. Histological typing of tumors of the central nervous system. World Health Organisation International Histological Classification of Tumors. 2nd ed. Berlin: Springer-Verlag; 1993.
3. Chandler KL, Prados MD, Malec M, Wilson CB. Long-term survival in patients with glioblastoma multiforme. Neurosurgery. 1993;2:716-720.
4. Kleinberg L, Wallner K, Malkin MG. Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys. 1993;26:129-133.
5. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer. 1985;56:1106-1111.
6. Devaux BL, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy, and outcome. J Neurosurg. 1993;78:767-775.
7. Collins VP, James CD. Gene and chromosome alterations associated with the development of human gliomas. FASEB J. 1993;7:926-930.
8. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 for the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol. 1986;10:611-617.
9. Couldwell WT, Weiss MH, Law RE, Hinton DR. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas. J Neurosurg. 1995;82:461-468.
10. Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer. 1993;3:550-555.
11. Kim DK, Hoyt J, Bacchi C, et al. Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins. Neurosurgery. 1993;33:619-626.
12. Ganju U, Jenkins RB, O'Fallon JR, et al. Prognostic factors in gliomas: a multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers. Cancer. 1994;74:920-927.
13. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer. 1994;74:1921-1926.
14. Salmon I, Kiss R. Relationship between proliferative activity and ploidy level in a series of 530 human brain tumors including astrocytomas, meningiomas, schwannomas and metastases. Hum Pathol. 1993;24:329-335.
15. Coons SW, Johnson PC. Regional heterogeneity in the DNA content of human gliomas. Cancer. 1993;72:3052-3060.
16. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol. 1993;52:609-618.
17. Mundle S, Iftikhar A, Shetty V, et al. Novel in situ double labeling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem. 1994;42:1533-1537.
18. Berthe JV, Goldschmidt D, Salmon I, et al. Image cytometry analysis of Feulgen-stained nuclei in 72 lipomatous lesions including atypical lipomas and well-differentiated liposarcomas. Am J Clin Pathol. 1996;106:289-297.
19. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-363.
20. Kruczynski A, Salmon I, Camby I, et al. The characterization of nuclear DNA content, the proliferative activity and the immunohistochemical expression of GFAP, VIM, LEU-7, S-100, p53 and cathepsin D in primitive human glioblastoma multiformes (GBMs) versus human GBM cell lines grafted into the brains of nude mice. Int J Oncol. 1995;6:473-481.
21. VandenBerg SR. Current diagnostic concepts of astrocytic tumors. J Neuropathol Exp Neurol. 1992;51:644-657.
22. Kiss R, Salmon I, Camby I, Gras S, Pasteels JL. Characterization of factors in routine laboratory protocols which significantly influence the Feulgen reaction. J Histochem Cytochem. 1993;41:935-945.
23. Decaestecker C, Salmon I, Camby I, et al. Identification of high-versus lower-risk clinical sub-groups in the group of adult patients with supratentorial anaplastic astrocytomas. J Neuropathol Exp Neurol. 1995;54:371-384.
24. Gillapsy GE, Miller RH, Samols D, Goldthwait DA. Antigenic and differentiative heterogeneity among human glioblastomas. Cancer Lett. 1993;68:215-224.
25. Salmon I, Dewitte O, Pasteels JL, et al. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. J Neurosurg. 1994;80:877-883.
26. Salmon I, Kruczynski A, Camby I, et al. DNA histogram typing in a series of 707 tumors of the central and peripheral nervous system. Am J Surg Pathol. 1993;17:1020-1028.
27. Kiss R, Salmon I, Kruczynski A, Camby I, Pasteels JL, Van Ham P. Aneuploidy occurrence in human tumors, a logical-automaton approach. Ann Cell Pathol. 1995;9:95-111.
28. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13-20.
29. Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13:795-808.
30. Kruczynski A, Yeaton P, Darro F, et al. Characterization by means of Voronoi paving of the influence of anti-hormone and/or anti-growth factor antibodies on the in vitro cell kinetics of human colorectal neoplastic cell lines. Int J Oncol. 1996;8:483-492.
31. Salmon I, Rorive S, Camby I, et al. Stereotactic biopsies from astrocytic tumors: diagnostic information contributed by the quantitative chromatin pattern description. Anal Quant Cytol Histol. 1995;17:332-343.